Compare Repligen Corporation Common Stock (RGEN) vs Tower Semiconductor Ltd. Ordinary Shares (TSEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Tower Semiconductor Ltd. Ordinary Shares — how do they compare? Repligen Corporation Common Stock trades at $178.19 (market cap $11.14B), while Tower Semiconductor Ltd. Ordinary Shares trades at $205.8 (market cap $24.09B). The key difference: Tower Semiconductor Ltd. Ordinary Shares is far larger — about 2.2× Repligen Corporation Common Stock's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Tower Semiconductor Ltd. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Tower Semiconductor Ltd. Ordinary Shares for 6 Days on average.
| RGEN | TSEM | |
|---|---|---|
Market Cap | $11.14B | $24.09B |
Volume | 1,259,263 | 2,099,453 |
Sector | Health | Technology |
52-Week High | $194.57 | $316.85 |
52-Week Low | $102.87 | $72.74 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $11.02B | $22.75B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Tower Semiconductor (TSEM) trades at $222.20, up 2.63% today, amid a bearish technical signal despite strong quarterly earnings beats. The stock faces resistance near $225 with support at $210. Recent news highlights expansion in silicon photonics and SiGe partnerships for AI infrastructure, positioning the company in high-growth segments. Revenue reached $1.57B in 2025 with a net income margin of 16.94%, though valuation ratios like P/E of 87.85 suggest premium pricing.
Outlook remains positive driven by AI-driven demand and strategic partnerships, but high valuation and technical bearishness pose near-term risks. Analysts project a $302 consensus price target, implying significant upside, yet investors should monitor execution on growth initiatives and competitive pressures in the semiconductor foundry space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Tower Semiconductor Ltd. Ordinary Shares
Tower Semiconductor is a specialty semiconductor foundry that manufactures analog and mixed-signal chips for other companies.
Read more on TSEM →
